Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2012
09/11/2012US8263834 Soybean variety XB31S10
09/11/2012US8263832 Soybean variety A1016467
09/11/2012US8263831 Soybean variety A1016054
09/11/2012US8263830 Soybean variety A1015481
09/11/2012US8263829 Soybean variety A1015993
09/11/2012US8263827 Sclerotinia-resistant Brassica
09/11/2012US8263741 Artificial antibody polypeptides
09/11/2012US8263559 Feline granulocyte macrophage colony stimulating factor proteins
09/11/2012US8263412 Long wavelength engineered fluorescent proteins
09/11/2012US8263406 Transforming and embryonic stem cells with vector comprising marker proteins, incubating with hedgehog and/or retinoic acid and recovering nervous system tissues; treating spinal cord or nervous system injury
09/11/2012US8263405 Controllably degradable hydrogel for culturing cells to produce three-dimensionally organized cells
09/11/2012US8263404 Method for enriching rare cell subpopulations from blood
09/11/2012US8263403 Methods and compositions for stem cell self-renewal
09/11/2012US8263402 Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
09/11/2012US8263401 Adenylyl cyclase antibodies, compositions and uses thereof
09/11/2012US8263400 Method for expanding adult stem cells from blood and compositions and methods for using the same
09/11/2012US8263398 Promoter and viral vector containing the same
09/11/2012US8263394 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof
09/11/2012US8263376 Lipoxygenase
09/11/2012US8263362 Cytochrome P450S and uses thereof
09/11/2012US8263359 Method and device to fractionate stem cells
09/11/2012US8263349 Antibody specific for a mammalian sphingosine kinase type 2 isoform protein and methods of use thereof
09/11/2012US8263341 Assays that detect T1R expressing cells
09/11/2012US8263326 Compounds and methods for modulating activation of NF-κB
09/11/2012US8263089 Compounds and methods for treatment and diagnosis of chlamydial infection
09/11/2012US8263085 Gammaretrovirus associated with cancer
09/11/2012US8263067 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy
09/11/2012US8263066 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
09/11/2012US8263065 Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
09/11/2012US8261749 Augmentation and repair of vocal cord tissue defects
09/11/2012CA2675147C Use of an in vitro hemodynamic endothelial/smooth muscle cell co-culture model to identify new therapeutic targets for vascular disease
09/11/2012CA2510180C Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2
09/11/2012CA2493588C Functional cardiomyocytes from human embryonic stem cells
09/11/2012CA2489298C Novel antagonists of cxcr3-binding cxc chemokines
09/11/2012CA2451577C Gene delivery vectors with cell type specificity for mesenchymal stem cells
09/11/2012CA2395291C Five-helix protein
09/11/2012CA2343839C Cytokine receptor zalpha11
09/11/2012CA2272820C An improved method for the production and purification of adenoviral vectors
09/11/2012CA2257247C Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same
09/07/2012WO2012119103A2 Compositions and methods for mobilization of stem cells
09/07/2012WO2012119074A1 Apparatus and method for organizing three-dimensional cell structures using stiffness gradients and sacrificial gels
09/07/2012WO2012118988A1 Direct reprogramming of human fibroblasts to functional neurons under defined conditions
09/07/2012WO2012118857A2 Immunologically modified carbon nanotubes for cancer treatment
09/07/2012WO2012118806A2 Compositions and methods for detecting and treating cancer
09/07/2012WO2012118799A2 Cell culture system
09/07/2012WO2012118349A2 Differentiation and proliferation method for natural killer cells from cd14-positive monocytes
09/07/2012WO2012118305A2 Method for manufacturing allogeneic soft-tissue transplant having autologous stem cell transplanted therein
09/07/2012WO2012118304A2 Device for incubating allogeneic soft tissue implant
09/07/2012WO2012118097A1 Cell sheet having hyaluronic acid production ability and method for producing same
09/07/2012WO2012118092A1 Fusion protein
09/07/2012WO2012117968A1 Method for controlling genesis and/or differentiation of embryo
09/07/2012WO2012117855A1 (nucleic acid)-polysaccharide complex
09/07/2012WO2012117373A1 Genetically modified muscle cells which express neurotrophic factors
09/07/2012WO2012117333A1 Isolation and expansion of adult stem cells, their therapeutic composition and uses thereof
09/07/2012WO2012117254A1 Mammalian haploid embryonic stem cells
09/07/2012WO2012116699A1 Active vitamin d or analogs thereof for use in in vivo or in vitro fertilization
09/07/2012WO2012096461A3 Composition for suspension culturing of stem cells
09/07/2012WO2012078648A3 Novel method of cancer diagnosis and prognosis and prediction of response to therapy
09/07/2012WO2012074117A8 Efficient method for establishing induced pluripotent stem cells
09/07/2012WO2012061637A3 Hsv-1 epitopes and methods for using same
09/07/2012WO2012047354A3 Environmentally sensitive compositions
09/07/2012WO2012014076A3 Liver organoid, uses thereof and culture method for obtaining them
09/07/2012CA2828110A1 Cell culture system
09/06/2012US20120227134 Plants with Increased Yield
09/06/2012US20120227133 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
09/06/2012US20120227132 Cell number polynucleotides and polypeptides and methos of use thereof
09/06/2012US20120227131 Transgenic plants with enhanced agronomic traits
09/06/2012US20120227126 Barley cultivar moravian 115
09/06/2012US20120227125 Cotton Cultivar L-3233
09/06/2012US20120227124 Cotton Cultivar L-269
09/06/2012US20120227123 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline and oxidative conditions
09/06/2012US20120227122 Hybrid artichoke variety nun 4060 ar
09/06/2012US20120227121 Pumpkin hybrid pxt 13067440 iii
09/06/2012US20120227120 Hydrolases, nucleic acids encoding them and methods for making and using them
09/06/2012US20120227118 Mo-1 conditional knock-out non-human animal and uses thereof
09/06/2012US20120226062 Mutant delta-9 elongases and their use in making polyunsaturated fatty acids
09/06/2012US20120226055 Microbial production of 3,4-dihydroxybutyrate (3,4-dhba), 2,3- dihydroxybutyrate (2,3-dhba) and 3-hydroxybutyrolactone (3-hbl)
09/06/2012US20120226023 Cytomegalovirus surface protein complex for use in vaccines and as a drug target
09/06/2012US20120225936 Method for producing triptolide
09/06/2012US20120225933 Regulated expression systems
09/06/2012US20120225928 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
09/06/2012US20120225927 Compositions and methods for inhibiting expression of transthyretin
09/06/2012US20120225926 Amphiphilic macromolecules for nucleic acid delivery
09/06/2012US20120225894 Substituted Thienol[2,3-d] pyrimidines as HIV Inhibitors
09/06/2012US20120225883 Compounds for inflammation and immune-related uses
09/06/2012US20120225880 Pyrazole compounds and thiazole compounds as protein kinases inhibitors
09/06/2012US20120225871 Small-molecule modulators of trp-p8 activity
09/06/2012US20120225864 Methods and Compositions for Modulating Tau Levels
09/06/2012US20120225859 Pyrimidine derivatives used as pi-3 kinase inhibitors
09/06/2012US20120225824 Mullerian inhibiting substance (mis) analogues
09/06/2012US20120225814 Hydrogel-based vascular lineage cell growth media and uses thereof
09/06/2012US20120225809 Compounds for treating papilloma virus infection
09/06/2012US20120225485 Methods for producing synthetic surfaces that mimic collagen coated surfaces for cell culture
09/06/2012US20120225484 Human placental collagen compositions, and methods of making and using the same
09/06/2012US20120225483 Microsphere-Containing Cell Aggregate
09/06/2012US20120225482 Mammalian cx3c chemokine antibodies
09/06/2012US20120225481 T cell receptors
09/06/2012US20120225480 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
09/06/2012US20120225479 Thermostable variants of fibroblast growth factors
09/06/2012US20120225478 Anti-amyloid beta antibodies and their use